Sk Life Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for SK LIFE, and when can generic versions of SK LIFE drugs launch?
SK LIFE has one approved drug.
There is one US patent protecting SK LIFE drugs.
There are twenty patent family members on SK LIFE drugs in nineteen countries and ten supplementary protection certificates in ten countries.
Drugs and US Patents for Sk Life
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-003 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | See Plans and Pricing | Y | See Plans and Pricing | |||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | See Plans and Pricing | Y | See Plans and Pricing | |||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-003 | Mar 10, 2020 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sk Life Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20080005437 | See Plans and Pricing |
Taiwan | I398249 | See Plans and Pricing |
Russian Federation | 2418792 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sk Life Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1879873 | 19/2021 | Austria | See Plans and Pricing | PRODUCT NAME: CENOBAMAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1530 (MITTEILUNG) 20210330 |
1879873 | CA 2021 00015 | Denmark | See Plans and Pricing | PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330 |
1879873 | C202130027 | Spain | See Plans and Pricing | PRODUCT NAME: CENOBAMATO; NATIONAL AUTHORISATION NUMBER: EU/1/21/1530; DATE OF AUTHORISATION: 20210326; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1530; DATE OF FIRST AUTHORISATION IN EEA: 20210326 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.